The BMJ is an international peer reviewed medical journal and a fully “online first” publication. The BMJ’s vision is to be the world’s most influential and widely read medical journal. Our mission is to lead the debate on health and to engage, inform, and stimulate doctors, researchers, and other health professionals in ways that will improve outcomes for patients. We aim to help doctors to make better decisions.
Manage episode 292695968 series 1426075
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Esther Olvia to discuss tumor staging of endocervical carcinoma. Dr. Oliva is a Pathologist at Massachusetts General Hospital and Professor at Harvard Medical School and have been the recent past president of the International Society of Gynecologic Pathologists. She was born in Barcelona and trained under three giants of pathology, Dr. Robert E. Scully, Dr. Robert H. Young, and Dr. Jaime Prat. Highlights - Create awareness of difficulties encountered by pathologists when reporting findings on different cervical specimens for endocervical adenocarcinoma - Highlight efforts to reach consensus among pathologists to standardize reporting for cervical specimens with adenocarcinoma - Highlight the importance of synchronization between FIGO, TNM, and AJCC - Clarify important issues in staging of endocervical adenocarcinoma including but not limited to measuring grossly visible tumor, exophytic tumors, and circumferential tumors, approach when dealing with multiple specimens or multiple tumors, and reporting tumor at margins - Highlight areas that need more studies in order to provide useful recommendations, including ovarian involvement by endocervical adenocarcinoma, quantification of lymphovascular invasion, or evaluation of isolated tumor Cells among others.